Published in Oncology Business Week, May 30th, 2004
"Matrix metalloproteinases (MMPs) are responsible for the degradation of extracellular matrix and have an important role in turnout metastases. We investigated the role of MMP-2 and MMP-9 in Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). The serum samples of patients with HD (n=12), NHL (n=30) and healthy control (n=22) were analyzed for MMP-2 and MMP-9," scientists writing in the International Journal of Clinical Practice report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week